Biodesix, Inc. BDSX Fair Value Adjustment Of Warrants
Fair Value Adjustment Of Warrants at other companies
Other financials
Where this comes from
Reported directly by Biodesix, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FairValueAdjustmentOfWarrants.
The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biodesix, Inc.'s fair value adjustment of warrants.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biodesix, Inc.'s fair value adjustment of warrants?
- Biodesix, Inc. (BDSX) reported fair value adjustment of warrants of $200K in Q2 2025.
- What does fair value adjustment of warrants mean?
- This metric reflects the non-cash gains or losses resulting from the periodic revaluation of outstanding warrant liabilities to their current fair market value. Changes in this value are driven by fluctuations in the company's stock price and volatility, which can create significant non-operating volatility in the income statement. It is essential for assessing how equity-linked derivatives impact the company's reported financial results.